ArticleBritish journal of cancer2026

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.

Zhen Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.